The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.

David R Boyer1,2,3,4,5, Binsen Li4,6, Chuanqi Sun4,6

  • 1Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095.

Summary

The E46K mutation in alpha-synuclein (α-synuclein) creates a more stable, pathogenic fibril structure. This hereditary mutation, linked to Parkinson's disease, alters the protein's fold, potentially explaining disease mechanisms.